Industry round-up: Kodak, Philips, Neutrino, SonoSite
Eastman Kodak Company has filed its submission with Health Canada for approval of its computed radiography (CR) system for mammography in the country. The CR mammography platform enables healthcare professionals to capture high-resolution mammography images with traditional x-ray equipment. The filings are part of Kodak’s plan for obtaining regulatory approval in Canada for its KODAK DIRECTVIEW CR Mammography Feature for CR 850/950/975 Systems. Kodak has submitted the final module of a pre-market approval submission (PMA) to the U.S. FDA for approval of the system. Meanwhile, the system is already available for sale in Europe, Greater Asia, Japan and Latin America, and Kodak has installed hundreds of CR systems with this feature in facilities ranging from small clinics and breast imaging centers to large hospitals and medical centers.
Royal Philips Electronics has announced that Agencia Valenciana de la Salut, a member of the healthcare council in Spain’s Valencia region, has chosen SpeechMagic to optimize its radiology information system with speech recognition. This is the fourth region-wide success for Philips’ industrial grade speech recognition technology SpeechMagic within the last six months, following similar projects in France, Norway and Spain’s Castilla La Mancha region.
Hand-carried ultrasound developer SonoSite has prevailed in a patient dispute with Neutrino Development Corporation (Neutrino) that played out in the United States Court of Appeals. In March 2006, the United States District Court for the Southern District of Texas, Houston Division, granted SonoSite’s motion for summary judgment, and reversed its earlier finding that SonoSite infringed Neutrino’s patent, US Patent No. 6,221,021. Neutrino had appealed the district court decision to the Federal Circuit, a specialized appellate court that hears patent appeals. The unanimous decision in favor of SonoSite was issued on December 12. Neutrino originally filed its complaint against SonoSite in July of 2001 alleging that SonoSite’s hand-carried ultrasound products infringed its ‘021 patent, entitled “Method and Apparatus for Penile Hemodynamic Stimulation, Monitoring and Drug Delivery Acceleration.”
Royal Philips Electronics has announced that Agencia Valenciana de la Salut, a member of the healthcare council in Spain’s Valencia region, has chosen SpeechMagic to optimize its radiology information system with speech recognition. This is the fourth region-wide success for Philips’ industrial grade speech recognition technology SpeechMagic within the last six months, following similar projects in France, Norway and Spain’s Castilla La Mancha region.
Hand-carried ultrasound developer SonoSite has prevailed in a patient dispute with Neutrino Development Corporation (Neutrino) that played out in the United States Court of Appeals. In March 2006, the United States District Court for the Southern District of Texas, Houston Division, granted SonoSite’s motion for summary judgment, and reversed its earlier finding that SonoSite infringed Neutrino’s patent, US Patent No. 6,221,021. Neutrino had appealed the district court decision to the Federal Circuit, a specialized appellate court that hears patent appeals. The unanimous decision in favor of SonoSite was issued on December 12. Neutrino originally filed its complaint against SonoSite in July of 2001 alleging that SonoSite’s hand-carried ultrasound products infringed its ‘021 patent, entitled “Method and Apparatus for Penile Hemodynamic Stimulation, Monitoring and Drug Delivery Acceleration.”